HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 1,466.00
-88.00 (-5.66%)
At close: May 29, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 68.07 billion as of May 29, 2026. Its market cap has decreased by -20.41% in one year.
Market Cap
68.07B
Enterprise Value
49.96B
Revenue
14.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,466.00
Market Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 68.07B, an increase of 293.69%. That is a compound annual growth rate of 5.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 66.66B | -15.55% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 295.29B |
| 3billion | 280.45B |
| GENINUS | 116.89B |
| Inventera | 110.67B |
| Cytogen | 98.16B |
| GC Medical Science | 96.53B |
| Protia | 54.99B |
| Seoulin Bioscience | 50.16B |